View Cart  

FDA, Roche Warn on Counterfeit Avastin Entering U.S. Via Unauthorized Supplier

A A
Counterfeit versions of Genentech’s cancer drug Avastin are circulating in the U.S. supply chain after 19 practitioners bought the drug from an unauthorized foreign supplier, the FDA and the Swiss-owned drugmaker warn.

To View This Article:

Login

Subscribe To Drug Industry Daily